Aerovate Therapeutics, Inc.

NASDAQ:AVTE

2.68 (USD) • At close April 28, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 000.1120000.136000000000000000
Kosten van de omzet 000.05600.0280.0280.0280.0250.0220.0210.020.020.0170.0110.0080.00300.0020000
Brutowinst 000.0560-0.028-0.028-0.028-0.025-0.022-0.021-0.02-0.02-0.017-0.011-0.008-0.003-0.002-0.0020000
Brutowinstmarge 000.5000-0.206000000000000000
Onderzoek- en ontwikkelingskosten 22.54701.53110.32821.24820.0817.81316.88416.03413.48812.22110.7838.3637.2555.0463.4184.3272.1963.2971.9661.4711.206
Algemene en administratieve kosten 5.2313.3874.8727.0824.9174.5384.2534.4844.3024.1513.6313.3693.8523.7643.2222.7821.4470.5840.3660.2770.1540.152
Verkoop- en marketingkosten 00000-0.028-0.028000000000000000
Verkoop-, algemene en administratieve kosten 5.2313.3874.8727.0824.9174.514.2254.4844.3024.1513.6313.3693.8523.7643.2222.7821.4470.5840.3660.2770.1540.152
Overige kosten 00000-0.0030.0010.001-0.001-0.001-0.0770.004-0.00600.0010-0.003-0.001-0.003000
Bedrijfskosten 27.7783.3876.40317.4126.16524.5922.03821.36820.33617.63915.85214.15212.21511.0198.2686.25.7742.783.6632.2431.6251.358
Bedrijfsresultaat -27.778-3.387-6.403-17.41-26.165-24.618-22.066-21.368-20.336-17.639-15.852-14.152-12.215-11.019-8.268-6.2-5.774-2.78-3.663-2.243-1.625-1.358
Bedrijfsresultaat ratio 00-57.17000-162.25000000000000000
Totaal overige inkomsten en kosten netto -4.3560.8691.0281.1731.391.4321.7091.8051.3111.1190.8550.5640.2240.1090.0480.016-0.001-0.001-0.003-0.064-0.577-0.078
Inkomen voor belasting -32.134-2.518-5.375-16.237-24.775-23.186-20.357-19.563-19.025-16.52-14.997-13.588-11.991-10.91-8.22-6.184-5.775-2.781-3.666-2.307-2.202-1.436
Inkomen voor belasting ratio 00-47.991000-149.684000000000000000
Belastingkosten 000.05500-0.0150.056-0.0250-1.1190.025-0.564-0.22400.0030-0.002-0.0010000
Nettowinst -32.134-2.518-5.43-16.237-24.775-23.186-20.413-19.563-19.025-15.401-15.022-13.024-11.767-10.801-8.223-6.184-5.775-2.781-3.666-2.307-2.202-1.436
Nettowinstmarge 00-48.482000-150.096000000000000000
WPA (Winst Per Aandeel) -863.46-0.09-0.19-0.56-0.86-0.83-0.74-0.71-0.76-0.62-0.61-0.56-0.49-0.45-0.34-0.26-23.8-0.13-15.08-10.12-9.06-0.32
Verwaterde WPA -863.46-0.09-0.19-0.56-0.86-0.83-0.74-0.71-0.76-0.62-0.61-0.56-0.49-0.45-0.34-0.26-23.8-0.13-15.08-10.12-9.06-0.32
EBITDA -27.778-3.387-6.395-17.192-26.137-24.59-22.038-21.343-20.314-17.618-15.832-14.132-12.198-11.008-8.26-6.197-5.772-2.778-4.309-2.243-1.625-1.398
EBITDA ratio 00-57.098000-162.044000000000000000